Page last updated: 2024-08-20

dextrothyroxine and Cranial Nerve II Diseases

dextrothyroxine has been researched along with Cranial Nerve II Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abiose, A; Alexander, ND; Babalola, OE; Cassels-Brown, A; Cousens, SN; Evans, J; Ibrahim, UF; Jones, BR; Murdoch, I; Nuhu, I1
Mabey, D1

Trials

1 trial(s) available for dextrothyroxine and Cranial Nerve II Diseases

ArticleYear
Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis.
    Lancet (London, England), 1993, Jan-16, Volume: 341, Issue:8838

    Topics: Adolescent; Adult; Aged; Animals; Double-Blind Method; Drug Administration Schedule; Female; Humans; Incidence; Ivermectin; Male; Microfilariae; Middle Aged; Onchocerca; Onchocerciasis; Onchocerciasis, Ocular; Optic Nerve Diseases; Regression Analysis

1993

Other Studies

1 other study(ies) available for dextrothyroxine and Cranial Nerve II Diseases

ArticleYear
Ivermectin and onchocercal optic nerve lesions.
    Lancet (London, England), 1993, Jan-16, Volume: 341, Issue:8838

    Topics: Humans; Ivermectin; Onchocerciasis; Optic Nerve Diseases

1993